Research and Development Expense (TTM) Chart

Historical Research and Development Expense (TTM) Data

View and export this data back to 2020. Start Trial.
Date Value
March 31, 2026 0.0043M
March 31, 2025 0.0143M
December 31, 2024 0.0141M
September 30, 2024
June 30, 2024
March 31, 2024
December 31, 2023
September 30, 2023
June 30, 2023
March 31, 2023
Date Value
December 31, 2022
September 30, 2022 0.0236M
June 30, 2022 0.0205M
March 31, 2022 0.0254M
December 31, 2021 0.0177M
September 30, 2021 0.0154M
June 30, 2021 0.0154M
March 31, 2021 0.0104M
December 31, 2020 0.1022M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Oncolytics Biotech, Inc. 13.18M
Sangamo Therapeutics, Inc. 113.79M
Sarepta Therapeutics, Inc. 647.26M
Anixa Biosciences, Inc. 4.828M
Protagenic Therapeutics, Inc. 0.3714M